318 related articles for article (PubMed ID: 30003818)
1. Novel treatment strategies and drugs in development for cryptosporidiosis.
Chavez MA; White AC
Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
[TBL] [Abstract][Full Text] [Related]
2. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
[TBL] [Abstract][Full Text] [Related]
3. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice.
Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC
J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial.
Nachipo P; Hermann D; Quinnan G; Gordon MA; Van Voorhis WC; Iroh Tam PY
Trials; 2018 Aug; 19(1):456. PubMed ID: 30139372
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better.
Caravedo MA; White AC
Expert Rev Anti Infect Ther; 2023 Feb; 21(2):167-173. PubMed ID: 36533398
[TBL] [Abstract][Full Text] [Related]
6. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic screening techniques for
Love MS; McNamara CW
Expert Opin Drug Discov; 2021 Jan; 16(1):59-74. PubMed ID: 32892652
[No Abstract] [Full Text] [Related]
8. Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model.
Stebbins E; Jumani RS; Klopfer C; Barlow J; Miller P; Campbell MA; Meyers MJ; Griggs DW; Huston CD
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006183. PubMed ID: 29309415
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis.
Zhang CX; Love MS; McNamara CW; Chi V; Woods AK; Joseph S; Schaefer DA; Betzer DP; Riggs MW; Iroh Tam PY; Van Voorhis WC; Arnold SLM
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0156021. PubMed ID: 34748385
[TBL] [Abstract][Full Text] [Related]
10. Novel drug targets for treatment of cryptosporidiosis.
Wang B; Castellanos-Gonzalez A; White AC
Expert Opin Ther Targets; 2020 Sep; 24(9):915-922. PubMed ID: 32552166
[TBL] [Abstract][Full Text] [Related]
11. New Tools for Cryptosporidium Lead to New Hope for Cryptosporidiosis.
Ward HD
Trends Parasitol; 2017 Sep; 33(9):662-664. PubMed ID: 28750950
[TBL] [Abstract][Full Text] [Related]
12. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
Manjunatha UH; Chao AT; Leong FJ; Diagana TT
ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
[TBL] [Abstract][Full Text] [Related]
13. A novel CDPK1 inhibitor--a potential treatment for cryptosporidiosis in calves?
Lendner M; Böttcher D; Delling C; Ojo KK; Van Voorhis WC; Daugschies A
Parasitol Res; 2015 Jan; 114(1):335-6. PubMed ID: 25398685
[TBL] [Abstract][Full Text] [Related]
14. Emerging treatment options for cryptosporidiosis.
Love MS; Choy RKM
Curr Opin Infect Dis; 2021 Oct; 34(5):455-462. PubMed ID: 34261904
[TBL] [Abstract][Full Text] [Related]
15. Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.
Schaefer DA; Betzer DP; Smith KD; Millman ZG; Michalski HC; Menchaca SE; Zambriski JA; Ojo KK; Hulverson MA; Arnold SL; Rivas KL; Vidadala RS; Huang W; Barrett LK; Maly DJ; Fan E; Van Voorhis WC; Riggs MW
J Infect Dis; 2016 Dec; 214(12):1856-1864. PubMed ID: 27923949
[TBL] [Abstract][Full Text] [Related]
16. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
[TBL] [Abstract][Full Text] [Related]
17. A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.
Manjunatha UH; Vinayak S; Zambriski JA; Chao AT; Sy T; Noble CG; Bonamy GMC; Kondreddi RR; Zou B; Gedeck P; Brooks CF; Herbert GT; Sateriale A; Tandel J; Noh S; Lakshminarayana SB; Lim SH; Goodman LB; Bodenreider C; Feng G; Zhang L; Blasco F; Wagner J; Leong FJ; Striepen B; Diagana TT
Nature; 2017 Jun; 546(7658):376-380. PubMed ID: 28562588
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cryptosporidiosis: do we know what we think we know?
Cabada MM; White AC
Curr Opin Infect Dis; 2010 Oct; 23(5):494-9. PubMed ID: 20689422
[TBL] [Abstract][Full Text] [Related]
19. Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
Hulverson MA; Vinayak S; Choi R; Schaefer DA; Castellanos-Gonzalez A; Vidadala RSR; Brooks CF; Herbert GT; Betzer DP; Whitman GR; Sparks HN; Arnold SLM; Rivas KL; Barrett LK; White AC; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC; Ojo KK
J Infect Dis; 2017 Apr; 215(8):1275-1284. PubMed ID: 28329187
[TBL] [Abstract][Full Text] [Related]
20. Drug treatment and novel drug target against Cryptosporidium.
Gargala G
Parasite; 2008 Sep; 15(3):275-81. PubMed ID: 18814694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
